TLR2 and cancer: The HSP70-binding A8 peptide aptamers were shown to form complexes with the exosome-expressed HSP70 and block its interaction with TLR2, thus preventing the exosome-mediated MDSC activation as well as the MDSC-conferred immune evasion of cancer cells [72].